ARCHIVES

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

NCI Cooperative Group, Cancer Center Trials Listed

January 25, 2008

ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS

June 7, 1985

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990